Iba1 immunoreactivity was much less variable than GFAP staining and revealed changes in morphology and increased Iba1 immunostaining in MPS IIIB dogs compared to the unaffected controls from 9 months of age, and were more pronounced at later stages (Fig. 9). The gene discussed is GFAP; the disease is mucopolysaccharidosis type 3B.